OnKure Therapeutics (NASDAQ:OKUR) Stock Quotes, Forecast and News Summary

Q: What sector and industry does OnKure Therapeutics (OKUR) operate in?

OnKure Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

OnKure Therapeutics Stock (NASDAQ: OKUR) stock price, news, charts, stock research, profile.

Open	$8.05
Close	$8.38
Volume / Avg.	500.89K / 83.56K
Day Range	$7.73 - $8.57
52 Wk Range	7.94 - 20.00
Market Cap	$113.39M
P/E Ratio	102.86
Dividend Yield	-
Exchange	NASDAQ
RSI	21
Short Interest	-
Days to Cover	22.67

Recent News

Recently Listed Cancer Firm OnKure's Innovative Approach to Breast Cancer Treatment Sparks Analyst Enthusiasm

OnKure Therapeutics has garnered attention following its merger with Reneo Pharmaceuticals and a $65 million private placement. Oppenheimer initiated coverage with an Outperform rating, highlighting the potential of OKI-219 in targeting breast cancer mutations.

Vandana Singh

This Builders FirstSource Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct

Nov

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$8.05
Close	$8.38
Volume / Avg.	500.89K / 83.56K
Day Range	$7.73 - $8.57
52 Wk Range	7.94 - 20.00
Market Cap	$113.39M
P/E Ratio	102.86
Dividend Yield	-
Exchange	NASDAQ
RSI	21
Short Interest	-
Days to Cover	22.67

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy OnKure Therapeutics (OKUR) stock?

You can purchase shares of OnKure Therapeutics (NASDAQ:OKUR) through any online brokerage.

View our list of the best stock brokerages

Who are OnKure Therapeutics (OKUR) competitors?

Other companies in OnKure Therapeutics’s space includes: Cabaletta Bio (NASDAQ:CABA), Adverum Biotechnologies (NASDAQ:ADVM), Atossa Therapeutics (NASDAQ:ATOS), Tonix Pharmaceuticals (NASDAQ:TNXP) and Lineage Cell Therapeutics (AMEX:LCTX).

What is the forecast, or price target, for OnKure Therapeutics (OKUR) stock?

OnKure Therapeutics has a consensus price target of $36.00.

What is the current price for OnKure Therapeutics (OKUR)?

The stock price for OnKure Therapeutics (NASDAQ: OKUR) is $8.5 last updated December 20, 2024 at 6:39 PM EST.

Does OnKure Therapeutics (OKUR) pay a dividend?

There are no upcoming dividends for OnKure Therapeutics.

When is OnKure Therapeutics (NASDAQ:OKUR) reporting earnings?

OnKure Therapeutics’s Q4 earnings are confirmed for Friday, February 14, 2025.

Is OnKure Therapeutics (OKUR) going to split?

There is no upcoming split for OnKure Therapeutics.

What sector and industry does OnKure Therapeutics (OKUR) operate in?

OnKure Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

OnKure Therapeutics

OnKure Therapeutics (OKUR) Forecast